title: Thirty five years of experience in the treatment of Parkinson's disease with levodopa and associations.
authors.affiliation: Section Extrapyramidal Diseases, Instituto de Neurología, Hospital de Clínicas, Facultad de Medicina, Universidad de la República Montevideo, Uruguay. chouza@hc.edu.uy
authors.forename: C
authors.initials: C
authors.lastname: Chouza
authors.forename: R
authors.initials: R
authors.lastname: Buzó
authors.forename: A
authors.initials: A
authors.lastname: Scaramelli
authors.forename: S
authors.initials: S
authors.lastname: Romero
authors.forename: O
authors.initials: O
authors.lastname: de Medina
authors.forename: R
authors.initials: R
authors.lastname: Aljanati
authors.forename: E
authors.initials: E
authors.lastname: Dieguez
authors.forename: N
authors.initials: N
authors.lastname: Lisanti
authors.forename: J
authors.initials: J
authors.lastname: Gomensoro
mesh_terms: D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced; D049673:History, 20th Century; D006801:Humans; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy* / Q000266:history / Q000503:physiopathology
chemical_list: D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007980:Levodopa